Literature DB >> 22981729

Impact of delay after biopsy and post-biopsy haemorrhage on prostate cancer tumour detection using multi-parametric MRI: a multi-reader study.

A B Rosenkrantz1, T C Mussi, N Hindman, R P Lim, M X Kong, J S Babb, J Melamed, S S Taneja.   

Abstract

AIM: To assess impact of haemorrhage and delay after biopsy on prostate tumour detection using multi-parametric (MP) magnetic resonance imaging (MRI) assessment.
MATERIALS AND METHODS: Forty-four patients underwent prostate MRI at 1.5 T using a pelvic phased-array coil, including T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE) imaging, before prostatectomy. Three radiologists independently reviewed images during four sessions [T2WI, DWI, DCE, and all parameters combined (MP-MRI)] to assess for tumour in each sextant. In a separate session, readers reviewed T1WI to score the extent of haemorrhage per sextant. Accuracy was assessed using logistic regression for correlated data.
RESULTS: There was no significant difference in accuracy between readers for any session (p ≥ 0.166), and results were averaged across the three readers for remaining comparisons. Accuracy was significantly greater for MP-MRI than for any parameter alone (p ≤ 0.020). For T2WI alone, there was a trend toward decreased sensitivity in sextants with extensive haemorrhage (p = 0.072). However, accuracy, sensitivity, and specificity were otherwise similar for sextants with and without extensive haemorrhage for all sessions (p = 0.192-0.934). No session showed a significant improvement in accuracy, sensitivity, or specificity in cases with delay after biopsy of over 4 weeks compared with shorter delay.
CONCLUSION: Extensive haemorrhage and short delay after biopsy did not negatively impact accuracy for tumour detection using MP-MRI. Further studies using MP-MRI protocols and interpretation schemes from other institutions are required to confirm these observations.
Copyright © 2012 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22981729     DOI: 10.1016/j.crad.2012.08.014

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  7 in total

1.  The Influence of Background Signal Intensity Changes on Cancer Detection in Prostate MRI.

Authors:  Andreas M Hötker; Evelyn Dappa; Yousef Mazaheri; Behfar Ehdaie; Junting Zheng; Marinela Capanu; Hedvig Hricak; Oguz Akin
Journal:  AJR Am J Roentgenol       Date:  2019-02-04       Impact factor: 3.959

Review 2.  Multiparametric MRI in prostate cancer management.

Authors:  Linda M Johnson; Baris Turkbey; William D Figg; Peter L Choyke
Journal:  Nat Rev Clin Oncol       Date:  2014-05-20       Impact factor: 66.675

3.  Multiparametric MR imaging of peripheral zone prostate cancer: effect of postbiopsy hemorrhage on cancer detection according to Gleason score and tumour volume.

Authors:  Sung Il Jung; Hae Jeong Jeon; Hee Sun Park; Mi Hye Yu; Young Jun Kim; Seung Eun Lee; So Dug Lim
Journal:  Br J Radiol       Date:  2018-03-09       Impact factor: 3.039

Review 4.  Implementation of Multi-parametric Prostate MRI in Clinical Practice.

Authors:  Andrea S Kierans; Samir S Taneja; Andrew B Rosenkrantz
Journal:  Curr Urol Rep       Date:  2015-08       Impact factor: 3.092

5.  Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.

Authors:  Cher Heng Tan; Brian Paul Hobbs; Wei Wei; Vikas Kundra
Journal:  AJR Am J Roentgenol       Date:  2015-04       Impact factor: 3.959

Review 6.  Multiparametric MRI for localized prostate cancer: lesion detection and staging.

Authors:  Daniel J A Margolis
Journal:  Biomed Res Int       Date:  2014-11-30       Impact factor: 3.411

Review 7.  Magnetic resonance imaging for prostate cancer: Comparative studies including radical prostatectomy specimens and template transperineal biopsy.

Authors:  Liam Toner; Mahesha Weerakoon; Damien M Bolton; Andrew Ryan; Nikolas Katelaris; Nathan Lawrentschuk
Journal:  Prostate Int       Date:  2015-10-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.